Showing 2961-2970 of 3039 results for "".
- Oyster Point Announces Positive Results From Two Phase 2b Clinical Trials of Investigational Treatments for Dry Eye Diseasehttps://modernod.com/news/oyster-point-announces-positive-results-from-two-phase-2b-clinical-trials-of-investigational-treatments-for-dry-eye-disease/2479733/Oyster Point Pharma announced results from the ONSET and RAINIER studies, two separate phase 2b clinical trials evaluating the company’s novel therapies for the treatment of dry eye disease (DED). Both studies, presented at the Ophthalmology Innovation Summit (OIS) meeting in Chicago, demonstrate
- Eyevance Pharmaceuticals Acquires Exclusive Rights to Commercialize Flarex in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-acquires-exclusive-rights-to-commercialize-flarex-in-the-united-states/2479751/Eyevance Pharmaceuticals announced the acquisition of Flarex (fluorometholone acetate ophthalmic suspension) 0.1% from Novartis AG. Flarex, approved in the United States, is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea,
- Aerie Pharmaceuticals Establishes GMP PRINT Production Facility in an Expanded Global Headquartershttps://modernod.com/news/aerie-pharmaceuticals-establishes-gmp-print-production-facility-in-an-expanded-global-headquarters/2479763/Aerie Pharmaceuticals announced that it has built and commenced operation of its GMP (Good Manufacturing Practices)-validated manufacturing facility for production of ophthalmic implants using the proprietary PRINT (Particle Replication in Non-wetting Templates) Technology platform. As a result o
- Oxurion Extends Partnership with Retina Global in Support of Bolivian Diabetic Retinopathy (BOLDR) Projecthttps://modernod.com/news/oxurion-extends-partnership-with-retina-global-in-support-of-bolivian-diabetic-retinopathy-boldr-project/2479770/Oxurion NV announced it is extending its partnership with Retina Global, an international nonprofit organization focused on sustainable outcomes to retinal disease management in underserved areas around the world. Oxurion will support Retina Global’s Bolivian Diabetic Retinopathy Project (BOLDR),
- Moorfields Dubai Hosts ‘World Association of Eye Hospitals’ Board Meetinghttps://modernod.com/news/moorfields-dubai-hosts-world-association-of-eye-hospitals-board-meeting/2479783/Dubai, the first overseas branch of the renowned Moorfields Eye Hospital London, will host the 2018 board meeting of the World Association of Eye Hospitals on Sunday November 4 at Moorfields Eye Hospital Dubai, which is located in Dub
- Pennsylvania Senate Approves Bill That Would Expand Optometrists’ Scope of Practicehttps://modernod.com/news/pennsylvania-senate-approves-bill-that-would-expand-optometrists-scope-of-practice/2479790/A Pennsylvania bill – Senate Bill (SB) 668, introduced by Sen. John Gordner – seeks to expand optometrists’ scope of practice beyond the limits of their training. The bill passed the full Senate by a vote of 32-17 on Sept. 25, 2018, and it now awaits consideration by the House Professional Licens
- Konan Medical USA Acquires objectiveFIELD Objective Perimeterhttps://modernod.com/news/konan-medical-usa-acquires-objectivefield-objective-perimeter/2479795/Konan Medical USA has acquired objectiveFIELD, an FDA-cleared device designed to assess the human visual field in an objective and non-contact manner. The device was acquired from the Australian National University (ANU), includes novel features licensed from Seeing Machine
- Dynamin-Binding Protein Linked to Congenital Cataractshttps://modernod.com/news/dynamin-binding-protein-linked-to-congenital-cataracts/2479813/A new study has now found compelling evidence that links dynamin-binding protein (DNMBP) to congenital bilateral cataracts and severe vision loss. The study appears in the
- The Refractive Surgery Council Rolls Out New “RSC Verified” Patient Education Program for Surgeonshttps://modernod.com/news/the-refractive-surgery-council-rolls-out-new-rsc-verified-patient-education-program-for-surgeons/2479820/Refractive surgeons who want to play a leading role in patient education and signal their commitment to quality now have a new resource: The RSC Verified program, according to The Refractive Surgery Council (RSC). The program, introduced by the RSC, opens the council’s vast library o
- Eyevance Acquires Global Rights to Persistent Corneal Epithelial Defect Treatment Nexagonhttps://modernod.com/news/eyevance-acquires-global-rights-to-persistent-corneal-epithelial-defect-treatment-nexagon/2479822/Eyevance Pharmaceuticals announced a worldwide licensing agreement with OcuNexus Therapeutics for Nexagon, a 30-base antisense oligomer being developed for the orphan indication of persistent corneal epithelial defect (PED) nonresponsive to standard of care. Terms of the deal were not disc